US EditionExclusive UniSafe distribution agreement between Owen Mumford and Nipro exceeds expectations in Japan with new biosimilar launch
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Exclusive UniSafe distribution agreement between Owen Mumford and Nipro exceeds expectations in Japan with new biosimilar launch
OXFORD – Owen Mumford, a global leader in medical devices, is pleased to announce that its exclusive agreement with Osaka-based Nipro Corp. to distribute drug delivery device UniSafe has achieved rapid early growth in combination product sales in Japan.The agreement has been in place since 2019 and has scored a major new product launch success in delivering a biosimilar product into the Japanese market. This biosimilar is used with cancer medici…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
